USPTO Granted Remand in Important Antibody Written Description Case

Patent

by Dennis Crouch

The Federal Circuit has remanded the Xencor appeal -- allowing USPTO  leadership an opportunity to re-focus on the written description requirement for both Jepson claims and means-plus-function claims in the antibody art.  I have several prior posts about the case:

To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.